Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats

U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.
FDA Layoffs Could Raise Drug Costs and Erode Food Safety

FDA Layoffs Could Raise Drug Costs and Erode Food Safety

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks

Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picks

Robert F. Kennedy Jr. and other candidates for top health posts are at odds with the drug industry, setting the stage for tense battles over regulatory changes.